サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571959

心臓マッピングの世界市場

Cardiac Mapping

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
心臓マッピングの世界市場
出版日: 2024年10月18日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓マッピングの世界市場は2030年までに37億米ドルに到達

2023年に22億米ドルと推定される心臓マッピングの世界市場は、分析期間2023-2030年にCAGR 7.7%で成長し、2030年には37億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである心房細動適応症は、CAGR 7.1％を記録し、分析期間終了までに12億米ドルに達すると予測されます。心房粗動適応症分野の成長率は、分析期間中CAGR 8.5%と推定されます。

米国市場は5億7,700万米ドルと推定、中国はCAGR11.5％で成長予測

米国の心臓マッピング市場は、2023年に5億7,700万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR11.5%を牽引し、2030年には予測市場規模9億980万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.0%と6.7%と予測されています。欧州では、ドイツがCAGR 4.6%で成長すると予測されています。

世界の心臓マッピング市場- 主要動向と促進要因まとめ

心臓マッピングとは何か、なぜ現代の心臓病学に不可欠なのか？

心臓マッピングは、心房細動、心室頻拍、その他の異常な心臓リズムなどの不整脈を特定し治療するために、心臓の電気的活動を可視化するために使用される高度な医療技術です。この技術により、心臓専門医は心臓の電気伝導系の詳細な3次元マップを作成し、異常な電気信号の発生源に関する正確な情報を提供することができます。心臓マッピングは不整脈の原因となる部位をピンポイントで特定することで、カテーテルアブレーションなどの治療介入を導くのに役立ち、現代の電気生理学において不可欠なツールとなっています。

世界的に心血管疾患（CVD）、特に不整脈の有病率が高まる中、心臓マッピングのような効果的な診断・治療ツールの必要性が高まっています。心臓マッピングが提供する精度は、より正確な診断を可能にし、効果のない治療のリスクを減らし、処置の侵襲を最小限に抑えます。さらに、心臓マッピングは、従来の診断方法では不整脈の根本原因を特定するのに十分でないような複雑な症例で使用されることが増えています。このような高度な診断への依存の高まりにより、心臓マッピングは心臓治療において必要不可欠なものとなっています。

技術の進歩は心臓マッピング市場をどのように形成していますか？

技術の進歩は心臓マッピング市場に革命をもたらし、より洗練され、正確で、ユーザーフレンドリーなシステムの開発につながっています。三次元（3D）電気解剖学的マッピングシステムのイントロダクションは、医師が心臓の電気経路をリアルタイムで可視化する能力を大幅に向上させました。これらのシステムは、カテーテル、センサー、画像モダリティなどさまざまなソースからのデータを統合し、非常に詳細なマップを作成することで、介入を驚くほど正確に誘導します。例えば、CARTO 3システムやEnSite Precisionシステムのようなシステムは、複雑な不整脈の診断と治療の方法を変えました。

さらに、ボディ・サーフェス・マッピング（BSM）のような非侵襲的マッピング技術の進歩は、侵襲的なカテーテル治療を必要とせずに詳細な心臓マッピングを可能にし、人気を集めています。これは患者の快適性を向上させるだけでなく、早期診断や経過観察におけるマッピングの応用範囲を広げます。人工知能（AI）と機械学習アルゴリズムの台頭は、信号解釈の精度を向上させることで心臓マッピングの能力をさらに高め、より迅速で正確な診断を可能にしています。このような技術革新により、心臓マッピングはより効率的で利用しやすく、臨床現場での価値が高まり、世界中の病院や心臓専門センターでの採用が進んでいます。

どのような患者やヘルスケアの動向が心臓マッピングの需要を牽引していますか？

心臓マッピング技術の需要には、いくつかの患者動向やヘルスケア動向が影響しています。心血管疾患、特に不整脈の発生率の増加は、主要な促進要因の一つです。世界人口の高齢化、高血圧、肥満、座りがちなライフスタイルなどの危険因子の増加により、心臓リズム障害の有病率は増加傾向にあります。心房細動や心室頻拍のような疾患と診断される患者が増えるにつれ、正確で効果的な治療法を提供する高度な診断ツールの必要性が高まり、心臓マッピングシステムへの依存度が高まっています。

もう一つの重要な動向は、個別化医療が重視されるようになっていることです。今日の患者は、特定の病状に対応した、よりオーダーメイドの治療を期待しています。心臓マッピングは、不整脈の原因を正確に特定し、心臓の特定部位を治療対象とすることで、循環器専門医がカスタマイズされた治療を提供することを可能にします。さらに、回復時間の短縮、痛みの軽減、合併症の減少といった患者の嗜好に後押しされ、低侵襲治療への需要が高まっています。心臓マッピング、特にガイディングカテーテルアブレーションは、不整脈治療のための低侵襲でありながら非常に効果的なソリューションを提供することで、この動向に合致しています。患者の期待とヘルスケア提供の進化に伴い、心臓マッピングのような精密診断に対する需要は拡大し続けています。

心臓マッピング市場の成長はいくつかの要因別もたらされる

心臓マッピング市場の成長は、心血管疾患の有病率の増加、電気生理学的技術の進歩、低侵襲手術に対する需要の高まりなど、いくつかの要因によってもたらされます。主要な促進要因の1つは、不整脈やその他の心臓リズム障害と診断される患者数の増加です。特に生活習慣や高齢化により不整脈患者が世界的に増加する中、心臓専門医が心臓の電気的活動を正確にマッピングし、的確な治療を行うための効果的な診断ツールの必要性が高まっています。

心臓マッピングシステムの技術的進歩も市場の成長を後押ししています。3D電気解剖学的マッピングシステム、非侵襲的体表面マッピング、AIを搭載した診断ツールの開発により、不整脈の診断と治療の精度と効率が向上しています。これらの技術革新により、心臓マッピングシステムは病院や専門センターにとってより利用しやすくなり、市場はさらに拡大しています。さらに、不整脈治療に使用される低侵襲手技であるカテーテルアブレーションの採用が増加していることも、これらの手技を高精度にガイドする心臓マッピング技術の需要を押し上げています。

また、個別化医療や精密医療への注目が高まっていることも、市場成長を後押しする重要な要因となっています。心臓マッピングを使えば、患者一人ひとりの心臓の状態に応じた治療戦略が可能になるため、治療成績が向上し、再手術の必要性が減少します。さらに、世界中のヘルスケアシステムが患者ケアの向上と心血管疾患の負担軽減に重点を置く中、心臓マッピングはより効果的で個別化された心臓ケアを提供する上で極めて重要なツールとなりつつあります。こうした動向は、今後数年間も心臓マッピング市場の成長に拍車をかけると予想されます。

調査対象企業の例（全42件）

  • Abbott Laboratories
  • Acutus Medical
  • Angiodynamics
  • APN Health, LLC
  • Biosense Webster, Inc.（A Johnson & Johnson Company）
  • Biosig Technologies, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Catheter Precision, Inc.
  • Coremap
  • EP Solutions Sa
  • Epmap-System
  • Kardium, Inc.
  • Koninklijke Philips N.V.
  • Lepu Medical
  • Medtronic Plc
  • Microport Scientific Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP21435

Global Cardiac Mapping Market to Reach US$3.7 Billion by 2030

The global market for Cardiac Mapping estimated at US$2.2 Billion in the year 2023, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Atrial Fibrillation Indication, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Atrial Flutter Indication segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$577.0 Million While China is Forecast to Grow at 11.5% CAGR

The Cardiac Mapping market in the U.S. is estimated at US$577.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$909.8 Million by the year 2030 trailing a CAGR of 11.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Cardiac Mapping Market – Key Trends & Drivers Summarized

What Is Cardiac Mapping and Why Is It Essential in Modern Cardiology?

Cardiac mapping is an advanced medical technique used to visualize the electrical activity of the heart to identify and treat arrhythmias, such as atrial fibrillation, ventricular tachycardia, and other abnormal heart rhythms. This technique allows cardiologists to create detailed, three-dimensional maps of the heart’s electrical conduction system, offering precise information about the source of abnormal electrical signals. By pinpointing the locations responsible for arrhythmias, cardiac mapping helps guide therapeutic interventions such as catheter ablation, making it an essential tool in modern electrophysiology.

With the rising prevalence of cardiovascular diseases (CVDs) globally, particularly arrhythmias, the need for effective diagnosis and treatment tools like cardiac mapping is growing. The precision that cardiac mapping provides allows for more accurate diagnoses, reducing the risk of ineffective treatments and minimizing the invasiveness of procedures. Additionally, cardiac mapping is increasingly used in complex cases where traditional diagnostic methods may not be sufficient to determine the root cause of the arrhythmia. This growing reliance on sophisticated diagnostics is making cardiac mapping an indispensable part of cardiac care.

How Are Technological Advancements Shaping the Cardiac Mapping Market?

Technological advancements are revolutionizing the cardiac mapping market, leading to the development of more sophisticated, accurate, and user-friendly systems. The introduction of three-dimensional (3D) electroanatomical mapping systems has significantly enhanced the ability of physicians to visualize the heart's electrical pathways in real-time. These systems integrate data from various sources, such as catheters, sensors, and imaging modalities, to generate highly detailed maps that guide interventions with remarkable precision. For example, systems like the CARTO 3 system and the EnSite Precision system have transformed the way complex arrhythmias are diagnosed and treated.

Moreover, advancements in non-invasive mapping technologies, such as body surface mapping (BSM), are gaining traction as they allow for detailed cardiac mapping without the need for invasive catheterization. This not only improves patient comfort but also broadens the application of mapping in early diagnosis and follow-up care. The rise of artificial intelligence (AI) and machine learning algorithms is further enhancing the capabilities of cardiac mapping by improving the accuracy of signal interpretation, enabling faster and more accurate diagnoses. These technological innovations are making cardiac mapping more efficient, accessible, and valuable in clinical practice, driving its adoption in hospitals and specialized cardiac centers worldwide.

What Patient and Healthcare Trends Are Driving the Demand for Cardiac Mapping?

Several patient and healthcare trends are influencing the demand for cardiac mapping technologies. The increasing incidence of cardiovascular diseases, particularly arrhythmias, is one of the primary drivers. With an aging global population and rising risk factors such as hypertension, obesity, and sedentary lifestyles, the prevalence of heart rhythm disorders is on the rise. As more patients are diagnosed with conditions like atrial fibrillation and ventricular tachycardia, the need for advanced diagnostic tools that offer precise and effective treatment options is growing, leading to greater reliance on cardiac mapping systems.

Another key trend is the growing emphasis on personalized medicine. Patients today expect more tailored treatments that cater to their specific medical conditions. Cardiac mapping enables cardiologists to deliver customized therapies by accurately identifying the source of arrhythmias and targeting specific areas of the heart for treatment. Additionally, there is an increasing demand for minimally invasive procedures, driven by patients' preferences for shorter recovery times, reduced pain, and fewer complications. Cardiac mapping, particularly in guiding catheter ablation, aligns with this trend by offering a minimally invasive yet highly effective solution for treating arrhythmias. As patient expectations and healthcare delivery evolve, the demand for precision diagnostics like cardiac mapping continues to grow.

Growth in the Cardiac Mapping Market Is Driven by Several Factors

Growth in the cardiac mapping market is driven by several factors, including the increasing prevalence of cardiovascular diseases, advancements in electrophysiology technologies, and the rising demand for minimally invasive procedures. One of the key drivers is the growing number of patients diagnosed with arrhythmias and other heart rhythm disorders. As arrhythmia cases rise globally, particularly due to lifestyle factors and aging populations, there is an increasing need for effective diagnostic tools that enable cardiologists to accurately map the heart’s electrical activity and guide precise treatments.

Technological advancements in cardiac mapping systems are also fueling market growth. The development of 3D electroanatomical mapping systems, non-invasive body surface mapping, and AI-powered diagnostic tools is improving the accuracy and efficiency of arrhythmia diagnosis and treatment. These innovations are making cardiac mapping systems more accessible to hospitals and specialized centers, further expanding the market. Additionally, the increasing adoption of catheter ablation, a minimally invasive procedure used to treat arrhythmias, is boosting demand for cardiac mapping technologies that assist in guiding these procedures with high precision.

Another key factor driving market growth is the rising focus on personalized and precision medicine. Cardiac mapping allows for tailored treatment strategies based on the specific characteristics of each patient’s heart condition, improving outcomes and reducing the need for repeat procedures. Furthermore, as healthcare systems worldwide focus on improving patient care and reducing the burden of cardiovascular diseases, cardiac mapping is becoming a crucial tool in providing more effective and personalized cardiac care. These trends are expected to continue fueling the growth of the cardiac mapping market in the coming years.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Acutus Medical
  • Angiodynamics
  • APN Health, LLC
  • Biosense Webster, Inc. (A Johnson & Johnson Company)
  • Biosig Technologies, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Catheter Precision, Inc.
  • Coremap
  • EP Solutions Sa
  • Epmap-System
  • Kardium, Inc.
  • Koninklijke Philips N.V.
  • Lepu Medical
  • Medtronic Plc
  • Microport Scientific Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Cardiac Mapping - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Globally Drives Demand for Advanced Cardiac Mapping Solutions in Diagnosis and Treatment
    • Increasing Demand for Minimally Invasive Cardiac Procedures Strengthens Market Position of Advanced Cardiac Mapping Technologies
    • Technological Advancements in 3D Mapping and Real-Time Visualization Propel Adoption of Cardiac Mapping in Electrophysiology
    • Growing Focus on Personalized Medicine and Precision Cardiology Expands Addressable Market for Cardiac Mapping Solutions
    • Rising Adoption of Cardiac Mapping in Atrial Fibrillation Treatment Creates New Growth Opportunities in Cardiology
    • Improving Accuracy and Resolution in Mapping Systems Drives Demand for High-Definition Cardiac Mapping in Complex Arrhythmias
    • Growing Integration of Cardiac Mapping with Robotic-Assisted Catheter Navigation Enhances Precision in Cardiac Interventions
    • Increasing Number of Cardiac Electrophysiology Labs and Specialty Clinics Expands Market Potential for Cardiac Mapping Systems
    • Rising Patient Awareness of Arrhythmia Risks and Treatments Drives Demand for Non-Invasive Cardiac Mapping Technologies
    • Development of Portable and Wearable Mapping Solutions for Continuous Monitoring Spurs Growth in Home and Outpatient Cardiac Care
    • Growing Use of Artificial Intelligence in Mapping Algorithms Enhances Efficiency and Predictive Capabilities of Cardiac Mapping Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cardiac Mapping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Atrial Fibrillation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Atrial Fibrillation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Atrial Fibrillation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Atrial Flutter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Atrial Flutter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Atrial Flutter by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for AVNRT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for AVNRT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for AVNRT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other Arrhythmias by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Contact Cardiac Mapping Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Contact Cardiac Mapping Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Contact Cardiac Mapping Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Non-Contact Cardiac Mapping Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Non-Contact Cardiac Mapping Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Non-Contact Cardiac Mapping Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Cardiac Mapping Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Cardiac Mapping by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Cardiac Mapping by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • INDIA
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Cardiac Mapping by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Cardiac Mapping by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • AFRICA
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030

IV. COMPETITION